Subgroup and covariate analyses with risk differences of sCR/CR rates at day 60 posttransplant (intention-to-treat population). IgA, immunoglobulin A; IMWG, International Myeloma Working Group; ISS, International Staging System; NS, not significant; PBSC, peripheral blood stem cells; PD, progressive disease; PR, partial response; SD, stable disease.